XML 29 R14.htm IDEA: XBRL DOCUMENT v3.8.0.1
Share-Based Compensation
 12 Months Ended
Dec. 31, 2017
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
Share-Based Compensation
Share-Based Compensation
Share-Based Incentive Compensation Plans
Under the Company's 2017 Omnibus Incentive Compensation Plan, effective as of June 7, 2017 (the "2017 Omnibus Plan"), there were 1,714,952 shares of common stock available for grant as of December 31, 2017.
Share-Based Compensation Expense
The table below reflects the total share-based compensation expense recognized in our Consolidated Statements of Comprehensive Income for the years ended December 31, 2017, 2016 and 2015.
 
2017
 
2016
 
2015
 
 
 
Restricted
 
 
 
Restricted
 
 
 
Restricted
Income Statement Classification
Options (1)
 
Shares (2)
 
Options (1)
 
Shares (2)
 
Options (1)
 
Shares (2)
Direct cost of revenues
$
370

 
$
9,691

 
$
2,815

 
$
7,530

 
$
3,736

 
$
6,532

Selling, general and administrative expenses
1,238

 
4,839

 
966

 
9,117

 
1,482

 
7,469

Special charges
—

 
269

 
56

 
49

 
—

 
—

Total
$
1,608

 
$
14,799

 
$
3,837

 
$
16,696

 
$
5,218

 
$
14,001

 
(1) 
Includes options and cash-settled stock appreciation rights.
(2) 
Includes restricted share awards, restricted stock units, performance stock units and cash-settled restricted stock units.

Stock Options
We use the Black-Scholes option-pricing model to fair value our option grants using the assumptions in the following table.
 
Year Ended December 31,
Assumptions
2017
 
2016
 
2015
Risk-free interest rate
1.60%
 
0.98%
 
1.07%-1.70%
Dividend yield
0%
 
0%
 
0%
Expected term
3 years
 
3 years
 
3-5 years
Stock price volatility
31.94%
 
34.33%
 
31.03%-40.36%

A summary of our stock option activity during the year ended December 31, 2017 is presented below. The aggregate intrinsic value for stock options outstanding and exercisable, or fully vested, at December 31, 2017 in the table below represents the total pre-tax intrinsic value, which is calculated as the difference between the closing price of our common stock on the last trading day of 2017 and the exercise price, multiplied by the number of in-the-money options that would have been received by the option holders had all option holders exercised their options on December 31, 2017. The aggregate intrinsic value changes based on fluctuations in the fair market value per share of our common stock. 
 
Options
 
Weighted
Average
Exercise
Price
 
Weighted
Average
Remaining
Contractual
Term
(in Years)
 
Aggregate
Intrinsic
Value
Stock options outstanding at December 31, 2016
2,418

 
$
40.79

 
 
 
 
Stock options granted
131

 
$
40.36

 
 
 
 
Stock options exercised
(123
)
 
$
33.69

 
 
 
 
Stock options forfeited
(168
)
 
$
47.76

 
 
 
 
Stock options outstanding at December 31, 2017
2,258

 
$
40.63

 
4.4
 
$
11,724

Stock options exercisable at December 31, 2017
1,683

 
$
42.32

 
3.5
 
$
7,531


Cash received from option exercises for the years ended December 31, 2017, 2016 and 2015 was $4.1 million, $27.3 million and $21.1 million, respectively. The actual tax benefit realized from stock options exercised totaled $1.1 million, $4.8 million and $5.5 million for the years ended December 31, 2017, 2016 and 2015, respectively.
The intrinsic value of stock options exercised is the amount by which the market value of our common stock on the exercise date exceeds the exercise price. The total intrinsic value of stock options exercised for the years ended December 31, 2017, 2016 and 2015 was $0.9 million, $6.9 million and $8.1 million, respectively. Prior to the adoption of ASU 2016-09, the excess (shortage) of the tax deduction versus the book expense was recorded to "Additional paid-in capital" in the Consolidated Balance Sheets. After the adoption, the excess tax benefit was recorded as a component of income tax expense in the Consolidated Statements of Comprehensive Income.
The following is a summary of stock options outstanding and exercisable as of December 31, 2017. 
 
Options Outstanding
 
Options Exercisable
 
 
 
Weighted
Average
Exercise
 
Weighted
Average
Remaining
Contractual
Term
 
 
 
Weighted
Average
Exercise
Exercise Price Range
Options
 
Price
 
(in Years)
 
Shares
 
Price
$26.68-$33.95
454

 
$
31.60

 
5.4
 
257

 
$
31.93

$34.33-$36.87
526

 
$
35.66

 
6.0
 
364

 
$
35.84

$36.89-$39.84
453

 
$
38.01

 
3.5
 
409

 
$
38.10

$40.36-$47.46
465

 
$
42.66

 
5.0
 
293

 
$
43.70

$50.62-$70.55
360

 
$
59.95

 
0.8
 
360

 
$
59.95

 
2,258

 
 
 
 
 
1,683

 
 

As of December 31, 2017, there was $2.5 million of unrecognized compensation cost related to unvested stock options. That cost is expected to be recognized ratably over a weighted average period of 1.5 years.
Restricted Share Awards
A summary of our unvested restricted share activity during the year ended December 31, 2017 is presented below.
 
Shares
 
Weighted
Average Grant
Date Fair
Value
Unvested restricted share awards outstanding at December 31, 2016
941

 
$
37.92

Restricted share awards granted
289

 
$
38.45

Restricted share awards vested
(251
)
 
$
36.16

Restricted share awards forfeited
(46
)
 
$
37.55

Unvested restricted share awards outstanding at December 31, 2017
933

 
$
38.58


As of December 31, 2017, there was $20.7 million of unrecognized compensation cost related to unvested restricted share awards. That cost is expected to be recognized ratably over a weighted average period of 4.3 years. The total fair value of restricted share awards that vested during the years ended December 31, 2017, 2016 and 2015 was $9.9 million, $10.4 million and $14.6 million, respectively.
Restricted Stock Units
A summary of our restricted stock units activity during the year ended December 31, 2017 is presented below. The aggregate intrinsic value represents the total pre-tax intrinsic value based on the closing price of our common stock on the last trading day of 2017.
 
Shares
 
Weighted
Average Grant
Date Fair
Value
 
Intrinsic
Value
Restricted stock units outstanding at December 31, 2016
465

 
$
37.87

 
 
Restricted stock units granted
50

 
$
38.35

 
 
Restricted stock units released
(113
)
 
$
39.47

 
 
Restricted stock units forfeited
—

 
$
—

 
 
Restricted stock units outstanding at December 31, 2017
402

 
$
37.49

 
$
17,287


The intrinsic value of restricted stock units released reflects the market value of our common stock on the date of release. The total intrinsic value of restricted stock units released for the years ended December 31, 2017, 2016 and 2015 was $4.1 million, $9.3 million and $3.1 million, respectively.
As of December 31, 2017, there was $0.3 million of unrecognized compensation cost related to unvested restricted stock units. That cost is expected to be recognized ratably over a weighted average period of 0.7 years. The total fair value of restricted stock units that vested during the years ended December 31, 2017, 2016 and 2015 was $1.9 million, $2.4 million and $4.4 million, respectively.
Performance Stock Units
A summary of our performance stock units activity during the year ended December 31, 2017 is presented below. The performance stock units are subject to market conditions based on the adjusted total shareholder return of the Company as compared with the adjusted total shareholder return of the adjusted Standard & Poor’s 500. The aggregate intrinsic value represents the total pre-tax intrinsic value based on the closing price of our common stock on the last trading day of 2017.
 
Shares
 
Weighted
Average Grant
Date Fair
Value
 
Intrinsic
Value
Performance stock units outstanding at December 31, 2016
206

 
$
26.64

 
 
Performance stock units granted
100

 
$
24.99

 
 
Performance stock units released
—

 
$
—

 
 
Performance stock units forfeited
(54
)
 
$
33.84

 
 
Performance stock units outstanding at December 31, 2017
252

 
$
25.71

 
$
10,818


As of December 31, 2017, there was $1.6 million of unrecognized compensation cost related to unvested performance stock units. That cost is expected to be recognized ratably over a weighted average period of 0.9 years. There are no performance stock units that vested during the years ended December 31, 2017, 2016 and 2015.
The table below reflects the weighted average grant date fair value per share of stock options, restricted share awards, restricted stock units and performance stock units awarded during the years ended December 31, 2017, 2016 and 2015. The fair value of our restricted stock awards and restricted stock units is determined based on the closing market price per share of our common stock on the grant date. The fair value of the performance stock units reflects the market conditions as of the grant date using a Monte Carlo simulation.
 
Year Ended December 31,
 
2017
 
2016
 
2015
Weighted average fair value of grants
 
 
 
 
 
Stock options
$
9.56

 
$
8.41

 
$
10.85

Restricted share awards, restricted stock units and performance stock units
$
38.88

 
$
37.64

 
$
39.01